Why Does my Shoulder Hurt? Understanding the Presence of Pain in Individuals With Full-thickness Rotator Cuff Tears
Why Does my Shoulder Hurt? Identifying Factors Associated With the Presence of Pain in Individuals With Full-thickness Rotator Cuff Tears
1 other identifier
observational
260
1 country
1
Brief Summary
Full-thickness rotator cuff tears (FTRCT), defined as "through-and-through" tears of one of the shoulder tendons, affect up to 32% of the population (mostly individuals older than 50 years) and are one of the most painful and debilitating shoulder diagnoses. One of the primary challenges for clinical decision-making is the poor association between the presence of FTRCT (detected by medical imaging) and pain, as studies have shown that 2/3 of people with FTRCT are asymptomatic. This challenges the notion that FTRCT causes pain, and highlights the fact that symptoms may be explained by other variables. A better understanding of the factors leading to the development of pain in people with FTRCT would optimize clinical care (including prevention). The objective of this study is to identify variables associated with pain in people with FTRCT by 1) comparing people with FTRCT with (Symptomatic Group; n=40) and without pain (Asymptomatic Group; n=40); 2) comparing people who initially have pain-free FTRCT (Asymptomatic Group) who develop pain over a 2-year period to those who do not develop pain; and 3) comparing people who initially have painful FTRCT (Symptomatic Group) who become pain-free over a 2-year period to those who remain symptomatic. All participants will undergo an ultrasound examination to confirm the presence of FTRCT, and information on a number of variables (sociodemographic, anatomical, genetic, psychosocial, pain sensitivity, neuromuscular, biomechanical) will be collected. All participants will then be followed for 2 years before being revaluated for pain. Variables will be analysed to determine those associated with pain. As it is crucial to improve our understanding of the mechanisms leading to pain, this project has the potential to impact the musculoskeletal health of Canadians. By considering multiple variables associated with FTRCT, its results could lead to the development of tangible solutions to optimize prevention and recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 5, 2018
CompletedFirst Submitted
Initial submission to the registry
August 9, 2018
CompletedFirst Posted
Study publicly available on registry
February 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2021
CompletedFebruary 20, 2020
February 1, 2020
3.6 years
August 9, 2018
February 19, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Change in usual shoulder pain from baseline: Visual analog scale (VAS)
Participants will be asked to rate the intensity of their pain on a VAS from 0 to 10, where "0" represents no pain and "10" represents "worst pain imaginable", in the last week, month and 3 months. Highest possible score (worst outcome): 30. Lowest possible score (best outcome): 0. Method to compute total score: sum of each score.
From baseline to the follow-up evaluation (end of the 2-year period) (Objective 2 and 3)
usual shoulder pain from baseline: Visual analog scale (VAS)
Participants will be asked to rate the intensity of their pain on a VAS from 0 to 10,
Baseline score (Objective 1)
Secondary Outcomes (38)
Change from baseline with regard to: Sociodemographic and occupational factors
From baseline to the follow-up evaluation (end of the 2-year period)(Objective 2 and 3)
Sociodemographic and occupational factors
Baseline characteristics (Objective 1)
Change in disability and functional limitations of the upper extremity from baseline: QuickDASH
From baseline to the follow-up evaluation (end of the 2-year period)(Objective 2 and 3)
Disability and functional limitations of the upper extremity QuickDASH
Baseline score (Objective 1)
Change in comorbidities from baseline: Self-Administered Comorbidity Questionnaire
From baseline to the follow-up evaluation (end of the 2-year period)(Objective 2 and 3)
- +33 more secondary outcomes
Study Arms (2)
Symptomatic
No intervention.
Asymptomatic
No intervention.
Eligibility Criteria
Adults aged 50 to 80 years presenting with symptomatic or asymptomatic full-thickness rotator cuff tears.
You may qualify if:
- Presence of a full-thickness rotator cuff tear (on ultrasound examination performed by a radiologist)
- to 80 years of age
- Degenerative tear (no significant trauma)
- unilateral or bilateral shoulder pain (at least 2/10 on a visual analog scale \[VAS\] evaluating usual shoulder pain)
- positive response to: 'In the past 4 weeks, have you had pain in your shoulder' and 'If yes, was this pain bad enough to limit your usual activities or change your daily routine for more than 1 day?'
- report no current shoulder pain (0/10 on a VAS evaluating usual shoulder pain)
- negative response to: 'In the past 4 weeks, have you had pain in your shoulder'
- do not report any past significant shoulder pain (any pain greater than or equal to 2/10 that lasted longer than 4 weeks, required the use of medications or prompted a physician visit)
You may not qualify if:
- unable to understand French or English;
- history of upper limb fracture;
- previous shoulder surgery;
- cervicobrachialgia or shoulder pain reproduced by neck movement;
- shoulder capsulitis (restriction of at least 30% in 2 or more directions);
- rheumatoid, inflammatory or neurological diseases;
- corticosteroid injection in the previous 6 weeks;
- cognitive problems interfering with evaluations (Mini-Mental State Examination ≥ 24)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Laval Universitylead
Study Sites (1)
Center for Interdisciplinary Research in Rehabilitation and Social Integration (CIRRIS)
Québec, Quebec, Canada
Biospecimen
DNA (saliva) samples will be collected at the baseline evaluation only. The samples will be analyzed for pain modulatory genes.
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Sébastien Roy, PT, PhD
Laval University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Faculty of Medicine
Study Record Dates
First Submitted
August 9, 2018
First Posted
February 27, 2019
Study Start
June 5, 2018
Primary Completion
December 30, 2021
Study Completion
December 30, 2021
Last Updated
February 20, 2020
Record last verified: 2020-02